Treatment-Stage Migration Maximizes Survival Outcomes In Patients With Hepatocellular Carcinoma Treated With Sorafenib: An Observational Study

C. Yen,Rohini Sharma,Lorenza Rimassa,Tadaaki Arizumi,D. Bettinger,J. Evans,T. Pressiani,M.E. Burlone,M. Pirisi,L. Giordano,Jessica Howell,Masatoshi Kudo,Robert Thimme,Joong Won Park,David J. Pinato

LIVER CANCER（2017）

引用 22|浏览7

暂无评分

摘要

Background: Level I evidence supports the use of sorafenib in patients with Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma, where heterogen

查看译文

关键词

Hepatocellular carcinoma,Sorafenib,Treatment stage migration,Prognosis,Treatment-naive patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要